Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma

Journal of Lipid Research

Volumn 39, Issue 7, 1998, Pages 1412-1420

  Björkegren, Johan ^a   Karpe, Fredrik ^a   Milne, Ross W ^b   Hamsten, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Alimentary lipemia; apoB 100; apoB 48; apoCs; apoE

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; APOLIPOPROTEIN C1; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; CHYLOMICRON; PHOSPHOLIPID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; DIET RESTRICTION; FAT INTAKE; HUMAN; HUMAN EXPERIMENT; HYPERLIPIDEMIA; IMMUNOAFFINITY CHROMATOGRAPHY; LIPID BLOOD LEVEL; LIPID COMPOSITION; MALE; NORMAL HUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL;

ADULT; APOLIPOPROTEIN C-I; APOLIPOPROTEIN C-II; APOLIPOPROTEIN C-III; APOLIPOPROTEINS; APOLIPOPROTEINS C; APOLIPOPROTEINS E; CHOLESTEROL; CHYLOMICRONS; FASTING; GENOTYPE; HUMANS; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; PHOSPHOLIPIDS; POSTPRANDIAL PERIOD; REFERENCE VALUES; TIME FACTORS; TRIGLYCERIDES;

EID: 0031856118     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Gotto, A. M. J., H. J. Pownall, and R. J. Havel. 1986. Introduction to the plasma lipoproteins. Methods Enzymol. 128: 3-41.
2. Kane, J. P., D. A. Hardman, and H. E. Paulus. 1980. Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. Proc. Natl. Acad. Sci. USA. 77: 2465-2469.
3. Havel, R. J., J. P. Kane, and M. L. Kashyap. 1973. Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. J. Clin. Invest. 52: 32-38.
4. Havel, R. J. 1995. Chylomicron remnants: hepatic receptors and metabolism. Curr. Opin. Lipidol. 6: 312-316.
5. Karpe, F., G. Steiner, T. Olivercrona, L. A. Carlson, and A. Hamsten. 1993. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J. Clin. Invest. 91: 748-759.
6. Björkegren, J., C. J. Packard, A. Hamsten, D. Bedford, M. Gaslake, J. Shepherd, L. Foster, P. Stewart, and F. Karpe. 1996. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. J. Lipid Res. 37: 76-86.
7. Schneeman, B. O., L., Kotite, K. M. Todd, and R. J. Havel. 1993. Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. Proc. Natl. Acad. Sci. USA. 90: 2069-2073.
8. Cohn, J. S., E. J. Johnson, J. S. Millar, S. D. Cohn, R. W. Milne, V. L. Marcel, R. M. Russell, and E. J. Sdiaefer. 1993. Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J. Lipid Res. 34: 2033-2040.
9. Ginsberg, H. N., J. Jones, W. S. Blaner, A. Thomas, W. Karmally, L. Fields, D. Blood, and M. D. Begg. 1995. Association of postprandial triglyceride and retinyl palmitate responses with newly diag̈nosed exercise-induced myocardial ischemia in middle age men and women. Arteriosrler. Thomb. Vasc. Biol. 15: 1829-1838.
10. Sharrett, A. R., L. E. Chambless, G. Heiss, S. C. Paton, and W. Patsch. 1995. Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle age men and women. Arterioscler. Thromb. Vasc. Biol. 15: 2122-2129.
11. Weintraub, M. S., I. Grosskopf, T. Rassin, H. Miller, G. Charach, H. H. Rotmensch, M. Liron, A. Rubinstein, and A. Iaina. 1996. Clearance of chylomicron remnants in normolipidemic patients with coronary heart disease: case control study over three years. Br. Med. J. 312: 935-939.
12. Karpe, F., G. Steiner, K. Uffelman, T. Olivecrona, and A. Hamsten. 1994. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis. 106: 83-97.
13. Tornvall, P., P. Båvenholm, C. Landou, U. de Faire, and A. Hamsten. 1993. Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction. Circulation. 88: 2180-2189.
14. Phillips, N. R., D. Waters, and R. J. Havel. 1993. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation. 88: 2762-2770.
15. Shimano, H., N. Yamada, M. Katsuki, K. Yamamoto, T. Gotoda, K. Harada, M. Shimada, and Y. Yazaki. 1992. Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B. J. Clin. Invest. 90: 2084-2091.
16. Aalto-Setälä, K., E. A. Fisher, X. Chen, T. Chajek-Shaul, T. Hayek, R. Zechner, A. Walsh, R. Ramakrishnan, H. N. Ginsberg, and J. L. Breslow. 1992. Mechanism of liypertriglyceridemia in human apolipoprotein (apo) C-III transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apoC-III and reduced apoE on the particles. J. Clin. Invest. 90: 1889-1900.
17. deSilva, H. V., S. J. Lauer, J. Wang, W. S. Simonet, K. H. Weisgraber, R. W. Mahley, and J. M. Taylor. 1994. Overexpression of human apolipoprotein C-III in transgenic mice results in a accumulation of apolipoprotein B-48 remnants that is corrected by excess apolipoprotein E. J. Biol. Chem. 269: 2324-2335.
18. Maeda, N., H. Li, D. Lee, P. Oliver, S. Quarfordt, and J. Osada. 1994. Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. J. Biol. Chem. 269: 23610-23616.
19. Shachler, N. S., T. Ebara, R. Ramakrishnan, G. Steiner, J. L. Breslow, H. N. Ginsberg, and J. D. Smith. 1996. Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein C-I. J. Clin. Invest. 98: 846-855.
20. Ebara, T., R. Ramakrishnan, G. Steiner, and N. S. Shachter. 1997. Chylomicronemia due to apolipoprotein C-III overexpression in apolipoprotein E-null mice. J. Clin. Invest. 99: 2672-2681.
21. Marcel, Y. L., M. Hogue, R. Theolis, and R. W. Milne. 1982. Mapping of antigenic determinants of human apolipoprotein B using monoclonal antibodies against LDL. J. Biol. Chem. 257: 13165-13168.
22. Milne, R. W., P. K. Weech, L. Blanchette, J. Davignon, P. I. Alaupovic, and Y. L. Marcel. 1984. Isolation and characterization of apolipoprotein B-48 and apoB-100 very low density lipoproteins from type III hyperlipoproteinemic subjects. J. Clin. Invest. 73: 816-823.
23. Carlson, K. 1973. Lipoprotein fractionation. J. Clin. Pathol. 26: 32-37.
24. Maagdenberg, A. M. V. D., P. deKnijff, A. F. Stalenhof, J. A. Gevers-Leuven, L. M. Havekes, and R. R. Frants. 1989. Apolipoprotein E3-Leiden allele results from a partial duplication in exon 4. Biochim. Biophys. Res. Commun. 165: 851-857.
25. Björkegren, J., A. Hamsten, R. W. Milne, and F. Karpe. 1997. Alterations of VLDL composition during alimentary lipemia. J. Lipid Res. 38: 301-314.
26. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
27. Zlatkis, A., B. Zak, and A. Boyle. 1953. A new method for direct determination of serum cholesterol. J. Lab. Clin. Med. 41: 486-492.
28. Karpe, F., and A. Hamsten. 1994. Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J. Lipid Res. 35: 1311-1317.
29. Bergeron, N., and R. J. Havel. 1996. Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein E4 allele. J. Clin. Invest. 97: 65-72.
30. Nakajima, K., M. Okazaki, A. Tanaka, C. R. Pullinger, T. Wang, M. Adachi, and R. J. Havel. 1996. Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apoB-100 and apoA-I. J. Clin. Lig. Ass. 19: 177-183.
31. Gianturco, S. H., F. B. Brown, A. M. J. Gotto, and W. A. Bradley. 1982. Receptor-mediated uptake of hypertriglyceridemic very low density lipoproteins by normal human fibroblasts. J. Lipid Res. 23: 984-993.
32. Agnani, G., J. M. Bard, L. Candelier, S. Delattre, J. C. Fruchart, and V Clavey. 1991. Interaction of LpB, LpB:E, LpBiC-III and LpB:C-III:E lipoproteins with the low density lipoprotein receptor of HeLa cells. Arterioscler. Thromb. 11: 1021-1029.
33. Björkegren, J., F. Karpe, S. Vitols, P. Tornvall, and A. Hamsten. 1998. Transient triglyceridemia in healthy normolipidemic men alters particle composition and increases cellular processing of large very low density lipoprotein in vitro. J. Lipid Res. 38: 423-436.
34. Kowal, R. C., J. Herz, K. H. Weisgraber, R. W. Mahley, M. S. Brown, and J. L. Goldstein. 1990. Opposing effects of apolipoproieins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J. Biol. Chem. 265: 10771-10779.
35. Ji, Z. S., D. A. Sanan, and R. W. Mahley. 1995. Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans. J. Lipid Res. 36: 583-592.
36. Sehayek, E., and S. Eisenberg. 1991. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J. Biol. Chem. 266: 18259-18267.
37. Karpe, F., T. Olivecrona, A. Hamsten, and M. Hultin. 1997. Chylomicron/chylomicron remnant turnover in humans: evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants. J. Lipid Res. 38: 949-961.
38. Shachter, N. S., T. Hayek, T. Leff, J. D. Smith, D. W. Rosenberg, A. Walsh, R. Ramakrishnan, I. J. Goldberg, H. N. Ginsberg, and J. L. Breslow. 1994. Overexpression of apolipoprotein C-II causes hypertriglyceridemia in transgenic mice. J. Clin. Invest. 93: 1683-1690.
39. Clavey, V., S. Lestavel-Delattre, C. Copin, J. M. Bard, and J. C. Fruchart. 1995. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins C-I, C-II, C-III and E. Artrrioscler. Thromb. Vasc. Biol. 15: 963-971.
40. Herbert, P. N., G., Assmann, A. M. Gotto, and D. S. Frederickson. 1983. Disorder of the lipoprotein and lipid metabolism. In The Metabolic Basis of Inherited Diseases. J. B. Stanbury, J. B. Wyngaarden, D. S. Frederickson, J. L. Goldstein, and M. S. Brown, editors. McGraw-Hill, New York. 589-651.
41. Ginsberg, H. N., N-A. Le, I. J. Goldberg, J. C. Gibson, A. Rubinstein, P. Wang-Iverson, R. Norum, and W. V. Brown. 1986. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins C-III and A-I. J. Clin. Invest. 78: 1287-1295.
42. Mann, C. J., F. T. Yen, A. M. Grant, and B. E. Bihain. 1991. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J. Clin. Invest. 88: 2059-2066.
43. Lasell, T. S., M. Guérin, S. Auboiron, M. J. Chapman, and B. Guy-Grand. 1998. Preferential cholesteryl ester acceptors among triglyceride-rich lipoproteins during alimentary lipemia in normolipidemic subjects. Arterioscler. Thromb. Vasc. Biol. 18: 65-74.
44. f 60-400 lipoproteins between plasma and arterial intima in humans. Arterioscler. Thromb. 11: 569-577.
45. Zilversmit, D. B. 1979. Atherogenesis: a postprandial phenomenon, Circulation. 60: 473-485.